Recently investigated models including both mutational signatures and phenotype selection performed well in the prediction of mutation prevalence, while models including only one of these factors did not, suggesting that the pattern of TP53 mutational hotspots is a consequence of both mutagenesis and selective forces that are active during tumor development [10]. Here, TP53 is linked to neoplasm.